Archive - August 2019
New cancer research could help boost immunotherapy treatments
Lilly’s atopic dermatitis drug hits endpoints
NICE to work with GW Pharma after Epidiolex rejection
The Case for Purpose-Built Pharma LIMS
J&J found liable in first opioid mis-marketing verdict
Positive multiple myeloma results for GSK
FDA Fast Track granted for AZ’ Forxiga
TMC rockets on data for twice-yearly cholesterol drug inclisiran